Karolinska Biomics Center

Publication 1 to 15 of 389 publications.

From the years: 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998, 1997, 1991 and 1987.
Next >>

Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K and Linderholm B

An Autocrine VEGF/VEGFR2 and p38 Signaling Loop Confers Resistance to 4-Hydroxytamoxifen in MCF-7 Breast Cancer Cells. Mol Cancer Res 6(10):1630-8. 2008

Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L and Lewensohn R

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 88(3):359-67. 2008

Jonmarker S, Glaessgen A, Culp WD, Pisa P, Lewensohn R, Ekman P, Valdman A and Egevad L

Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue. Apmis 116(6):491-8. 2008

Arsov Z, Nemec M, Schara M, Johansson H, Langel U and Zorko M

Cholesterol prevents interaction of the cell-penetrating peptide transportan with model lipid membranes. J Pept Sci . 2008

Eriksson H, Lengqvist J, Hedlund J, Uhlen K, Orre LM, Bjellqvist B, Persson B, Lehtio J and Jakobsson PJ

Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms. Proteomics 8(15):3008-18. 2008

Hoivik EA, Aumo L, Aesoy R, Lillefosse H, Lewis AE, Perrett RM, Stallings NR, Hanley NA and Bakke M

DNA methylation controls cell type specific expression of steroidogenic factor 1. Endocrinology . 2008

De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R and Lehtio J

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer . 2008

Pernemalm M, Orre LM, Lengqvist J, Wikstrom P, Lewensohn R and Lehtio J

Evaluation of Three Principally Different Intact Protein Prefractionation Methods for Plasma Biomarker Discovery. J Proteome Res . 2008

Massoner P, Haag P, Seifarth C, Jurgeit A, Rogatsch H, Doppler W, Bartsch G and Klocker H

Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction. Prostate 68(11):1165-78. 2008

Forshed J, Pernemalm M, Tan CS, Lindberg M, Kanter L, Pawitan Y, Lewensohn R, Stenke L and Lehtio J

Proteomic Data Analysis Workflow for Discovery of Candidate Biomarker Peaks Predictive of Clinical Outcome for Patients with Acute Myeloid Leukemia. J Proteome Res . 2008

Gridelli C, Ardizzoni A, Ciardiello F, Hanna N, Heymach JV, Perrone F, Rosell R, Shepherd FA, Thatcher N, Vansteenkiste J, De Petris L, Di Maio M and De Marinis F

Second-line treatment of advanced non-small cell lung cancer. J Thorac Oncol 3(4):430-40. 2008

Guterstam P, Lindgren M, Johansson H, Tedebark U, Wengel J, El Andaloussi S and Langel U

Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers. Biochem J 412(2):307-13. 2008

Wheelock CE, Forshed J, Goto S, Hammock BD and Newman JW

Effects of pyridine exposure upon structural lipid metabolism in Swiss Webster mice. Chem Res Toxicol 21(3):583-90. 2008

Holmstrom TH, Mialon A, Kallio M, Nymalm Y, Mannermaa L, Holm T, Johansson H, Black E, Gillespie D, Salminen TA, Langel U, Valdez BC and Westermarck J

c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21. J Biol Chem 283(11):7046-53. 2008

Nordstrom A, Want E, Northen T, Lehtio J and Siuzdak G

Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Anal Chem 80(2):421-9. 2008

Next >>